EU-funded PhD programme INCIPIT is pooling expertise from different research institutes and non-academic partners, providing innovative training and transferable skills to researchers in the fields of life and biomaterial sciences.
How can we explore the inside of a volcano? What are the conditions in caverns deep beneath the earth surface?
FET Open project Phoenix seeks to get information about places where humans have no or only extremely difficult access
What do research on personalised medicine, work towards safer aircraft, understanding turbulence and unravelling the structure of matter have in common? They all require high performance computing (HPC). An EU-funded project is creating the experts we will need to find the answers to these and other global questions using HPC.
EU-funded project SEPCELL will conduct a clinical trial of a stem cell treatment for patients with severe sepsis caused by a severe form of community-acquired bacterial pneumonia. The trial is one of a series of steps in assessing whether the treatment is safe and efficacious for patients with this life-threatening disease.
The sudden earthquakes that hit the headlines can be catastrophic. However, much slower ruptures release energy more safely. An EU-funded researcher is identifying how these little-understood slow ruptures occur, their precursory signals and how they are linked to fast earthquakes - information that could one day help develop early warning systems.
Nanocarriers are tiny substances that can be used to transport other materials, such as drugs, to specific areas of the body. The EU-funded TARGETCARE project plans to use them to treat joint and intervertebral disc diseases - improving patients' mobility and quality of life.
Drugs derived from biological sources play a major role in modern healthcare, but producing them cost-effectively to keep up with rising demand is a major challenge for the pharmaceutical industry. EU-funded researchers are developing more efficient biopharmaceutical manufacturing processes that should expand patients' access to these highly effective therapies.